Synthesis and stereochemical assignment of 7‐arylidene and 7‐heteroarylidene morphinan‐6‐ones
暂无分享,去创建一个
W. Dunn | Wei Xu | G. Doss | L. Bauer | Y. Nan | H. Bhargava | Kathrine E. Hughes | S. Upadhyaya
[1] R. Hartmann,et al. Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom. , 1995, Journal of medicinal chemistry.
[2] Michael P. Williamson,et al. Searching Conformational Space in Flexible Molecules Using NOEs and Molecular Modeling , 1995 .
[3] J. Flippen-Anderson,et al. Probes for narcotic receptor-mediated phenomena. 20. Alteration of opioid receptor subtype selectivity of the 5-(3-hydroxyphenyl)morphans by application of the message-address concept: preparation of delta-opioid receptor ligands. , 1995, Journal of medicinal chemistry.
[4] P. Portoghese,et al. Electrophilic N-benzylnaltrindoles as delta opioid receptor-selective antagonists. , 1995, Journal of medicinal chemistry.
[5] P. Portoghese,et al. Monophenylation of Morphinan-6-ones with Diphenyliodonium Iodide , 1995 .
[6] P. Portoghese,et al. 7'-Substituted amino acid conjugates of naltrindole. Hydrophilic groups as determinants of selective antagonism of delta 1 opioid receptor-mediated antinociception in mice. , 1995, Journal of medicinal chemistry.
[7] W. L. Nelson,et al. Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6 alpha- and 6 beta-naltrexol. , 1994, Journal of medicinal chemistry.
[8] W. L. Nelson,et al. Formation of an 6α,14-epoxy-bridged isomorphinan, an unusual product from a substituted 6α,14-dihydroxymorphinan , 1994 .
[9] R. Hartmann,et al. Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins. , 1994, Journal of medicinal chemistry.
[10] P. Portoghese,et al. Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety. , 1994, Journal of medicinal chemistry.
[11] P. Portoghese,et al. A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists. , 1993, Journal of medicinal chemistry.
[12] G. Caldwell,et al. Complete proton and carbon nuclear magnetic resonance spectral assignments of some morphinan‐6‐one alkaloids by two‐dimensional NMR techniques , 1993 .
[13] K. Görlitzer,et al. Zur Mannich‐Reaktion von Hydrocodon und Oxycodon , 1993 .
[14] W. L. Nelson,et al. O3-(2-carbomethoxyallyl) ethers of opioid ligands derived from oxymorphone, naltrexone, etorphine, diprenorphine, norbinaltorphimine, and naltrindole. Unexpected O3-dealkylation in the opioid radioligand displacement assay. , 1992, Journal of medicinal chemistry.
[15] P. Portoghese,et al. A highly selective δ1-opioid receptor antagonist : 7-benzylidenenaltrexone , 1992 .
[16] P. Portoghese,et al. Edward E. Smissman-Bristol-Myers Squibb Award Address. The role of concepts in structure-activity relationship studies of opioid ligands. , 1992, Journal of medicinal chemistry.
[17] R. Hartmann,et al. New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives. , 1991, Journal of medicinal chemistry.
[18] D. L. Larson,et al. Persistent binding of fatty acyl derivatives of naltrexamine to opioid receptors. , 1991, Journal of medicinal chemistry.
[19] P. Portoghese. An approach to the design of receptor-type-selective non-peptide antagonists of peptidergic receptors: delta opioid antagonists. , 1991, Journal of medicinal chemistry.
[20] P. Portoghese,et al. Role of spacer and address components in peptidomimetic delta opioid receptor antagonists related to naltrindole. , 1991, Journal of medicinal chemistry.
[21] D. Taylor,et al. Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 4. Effect of various side-chain substituents on therapeutic activity against anticholinesterase intoxication. , 1991, Journal of medicinal chemistry.
[22] P. Portoghese,et al. Role of the spacer in conferring kappa opioid receptor selectivity to bivalent ligands related to norbinaltorphimine. , 1991, Journal of medicinal chemistry.
[23] D. Zimmerman,et al. Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. , 1990, Journal of medicinal chemistry.
[24] P. Portoghese,et al. The facility of formation of a .DELTA.6 bond in dihydromorphinone and related opiates , 1989 .
[25] M. Noack,et al. Indoxyl‐δ‐aminosäuren aus Hydromorphon und Hydrocodon , 1986 .
[26] E. J. Simon,et al. Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone. , 1985, Journal of medicinal chemistry.
[27] J. Polazzi,et al. Analgesic narcotic antagonists. 8. 7 alpha-Alkyl-4,5 alpha-epoxymorphinan-6-ones. , 1981, Journal of medicinal chemistry.
[28] J. Polazzi. Mannich reaction product of dihydrocodeinone , 1981 .
[29] F. Carroll,et al. Ring C conformation of 6beta-naltrexol and 6alpha-naltrexol. Evidence from proton and carbon-13 nuclear magnetic resonance. , 1976, The Journal of organic chemistry.
[30] F. Carroll,et al. Carbon-13 nuclear magnetic resonance spectra of morphine alkaloids. , 1976, The Journal of organic chemistry.
[31] P. Portoghese. A new concept on the mode of interaction of narcotic analgesics with receptors. , 1965, Journal of medicinal chemistry.
[32] L. Birkofer,et al. Aldehydaddition an Enamine , 1962 .